[86] documented that RG7834, a novel oral HBV gene expression inhibitor, could decrease the levels of viral proteins and decreased viremia. RG7834 is a small-molecule compound belonging for the dihydroquinolizinones chemical class just like RNAi but by way of a unique mechanism. They found that Cas9-mediated base modifying is a https://mickj308aei1.prublogger.com/profile